PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Jul-2024 Autoclave Market Set to Reach USD 3.68 Billion by 2034, Driven by a CAGR of 4.7% MARKITWIRED
02-Jul-2024 Common Warts Market is expected to reach a significant value of US$ 1,100 Million by 2033, with a CAGR of 3.6% | FMI Study MARKITWIRED
02-Jul-2024 Microneedle Drug Delivery Systems Market to Achieve Significant Growth, Projected to Reach USD 1459.1 Million by 2033 with a CAGR of 6.6% MARKITWIRED
02-Jul-2024 Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to be valued US$ 62.37 Billion by 2033, at a CAGR of 6% | FMI MARKITWIRED
02-Jul-2024 Kinase Inhibitor in Autoimmune Diseases Market is Expecting a Growth and a Potential Value of US$ 80,252 Million by 2033, at a CAGR of 5.4% | FMI MARKITWIRED
02-Jul-2024 Pancreatic Cancer Market is expected to surpass USD 7,541.09 Million by 2033, growing at a 13.5% annual rate | FMI Study MARKITWIRED
02-Jul-2024 Non-Small Cell Lung Carcinoma Market is expected to reach USD 21.40 Billion by 2033, Driven by a 10% CAGR | FMI MARKITWIRED
02-Jul-2024 Food Allergy Market Expects to Reach a Major USD 66.15 Billion by 2033, Growing at a 5.2% CAGR | FMI Research MARKITWIRED
02-Jul-2024 Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine AccessWire
02-Jul-2024 Age Related Molecular Degeneration Market Expects to Reach a Record High of US$ 22.19 Million by 2033, at a steady CAGR of 7% | FMI MARKITWIRED
02-Jul-2024 CPHI returns to the Messe Frankfurt in 2025 Informa Markets
02-Jul-2024 Almirall launches Act4Impact – its updated sustainability strategy setting ambitious targets for 2030 Almirall
02-Jul-2024 Unlocking Growth in the USD 2.3 Billion Omega-3 Pet Supplement Market: Strategic Opportunities for Capitalizing on 7.9% CAGR through 2034 MARKITWIRED
02-Jul-2024 Capitalizing on the USD 20.8 Billion Animal Feed Sweetener Market: Strategic Insights for 8.7% CAGR Growth through 2034 MARKITWIRED
02-Jul-2024 Sobi initiates rolling biologics license application to FDA for SEL-212 for the potential treatment of chronic refractory gout Sob
02-Jul-2024 Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325 Mission Therapeutics
02-Jul-2024 ramarketing strengthens AI capabilities with key leadership appointments ramarketing
02-Jul-2024 Clinigen appoints Fernando Ballester as Chief Financial Officer Clinigen
02-Jul-2024 Capitalize on Versatility: Investing in the Buttermilk Powder Market Set to Reach USD 3.8 Billion by 2034 MARKITWIRED
02-Jul-2024 Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325 Mission Therapeutics